Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,958.80
(
1.33%
)
Dow Jones
49,447.43
(
1.88%
)
Brent Oil
88.87
(
0.00%
)
Bitcoin
77,111.26
(
-0.04%
)
News Focus
News Focus

Replies to post #21641 on Elite Pharmaceuticals Inc (ELTP)

Replies to #21641 on Elite Pharmaceuticals Inc (ELTP)
icon url

lasers

07/17/12 3:36 PM

#21648 RE: Steges #21641

As I envision 'Third Party Funding" Elite licenses and makes ELI-216 Morphine for Watson/Actavis in exchange for Watson/Actavis funding the ELI-216 Phase III trials of $6 to $7 mil.